“adnexus-therapeutics” Archives

Entry Author Date Location
Bio Roundup: CRISPR Appeal, Bristol Deals, Stock Pumping & More 04/14/17 National
With New Execs, Sanofi Backing, ImmuneXcite Begins Clinical Push 03/30/16 Boston
Katrine Bosley, Former Avila CEO, Takes Helm at Editas 06/24/14 Boston
Red (and Green) Flags To Look for With Biotech’s Buyside Investors 10/31/13 Boston
Can (Should?) A Young Biotech Company Still Go Long? 12/20/12 Boston
Flagship Closes New $270M Fund For Healthcare and Cleantech Ventures 01/11/12 Boston
Flagship VentureLabs, Creating and Spinning Out Cleantech and Life Sciences Startups for 10 Years, Takes the Veil Off 02/17/11 Boston
Bristol-Myers Squibb to Stay in Seattle, Keep ZymoGenetics Workers 01/25/11 Seattle
John Mendlein Tries His Hand as a ‘Parallel Entrepreneur,’ Santaris Continues RNA Therapeutics Work for Pfizer, & More San Diego Life Sciences News 01/06/11 San Diego
John Mendlein, Biotech Exec With Surfer Look, Follows Winding Path as “Parallel Entrepreneur” 01/03/11 San Diego
ATyr Pharma Pockets $23M to Create New Class of Protein Drugs, and New Targets 10/26/10 San Diego
Mendlein Joins aTyr as Chairman 05/26/10 San Diego
Avila Aims to Trump Vertex With Drug that Hits Hepatitis C Virus and Won’t Let Go 02/26/10 Boston
How Bad is the Biotech Climate? Think 4 on a Scale of 10 11/04/08 Boston
Year’s Best Exits—Top Massachusetts IPOs and M&As of 2007 01/09/08 Boston
The Boston-China Biopharma Connection 10/18/07 Boston
Clarus Ventures’ Very Big Deal, Color Kinetics’ Acquisition, VMware’s Upward Trek, and More 08/24/07 Boston
Page 1 of 1